Atypical Protein Kinase C Mediates Interleukin-1beta Induced Fibronectin Production in Cultured Human Peritoneal Mesothelial Cells (HPMCs).
- Author:
Won Seok YANG
1
;
Soon Bae KIM
;
Byung Sik KIM
;
Su Kil PARK
;
Jung Sik PARK
Author Information
1. Department of Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea. wsyang@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Peritoneal mesothelial cell;
Fibronectin;
Interleukin-1beta;
Protein kinase C zeta/iota
- MeSH:
Blotting, Northern;
Blotting, Western;
Fibronectins*;
Humans*;
Interleukin-1beta*;
Protein Kinase C*;
Protein Kinases*;
RNA, Messenger
- From:Korean Journal of Nephrology
2003;22(4):340-348
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Protein kinase C (PKC)s consist of three groups of isoenzyme; conventional, novel and atypical PKCs. Diacylglycerol (DAG) activates both conventional and novel PKCs, but not atypical PKCs. High glucose-induced fibronection production was shown to be mediated by activation of DAG-sensitive PKCs. In this study, we investigated whether PKC mediates IL-1beta-induced fibronectin mRNA expression, and the subtypes of PKC involved in the process. METHODS: Fibronectin mRNA level and phosphorylated PKC zeta/iota in total cell lysate were measured by Northern blot and Western blot, respectively. RESULTS: Pretreatment of HPMCs with calphostin C, a pan-PKC inhibitor, at doses of 500, 750 and 1, 000 nM caused dose-dependent inhibition of IL- 1beta (1 ng/mL)-induced fibronectin mRNA level. GF109203X, another pan-PKC inhibitor, at doses of 1, 5 and 10 microM also downregulated IL-1beta (1 ng/ mL)-induced fibronectin mRNA level in a dose-dependent manner. Phorbol 12-myristate 13-acetate (PMA), an activator of conventional and novel PKCs, stimulated fibronectin mRNA level at doses of 1, 10 and 100 nM. After prolonged treatment of the cells for 72 hr with PMA, another dose of PMA did not increase fibronectin mRNA level, while IL-1beta (1 ng/mL) still stimulated it. Pretreatment of the cells with 5, 10, 15 and 20 microM of myristoylated PKC zeta/iota pseudosubstrate inhibited IL-1beta (1 ng/mL)-induced fibronectin mRNA level in a dose-dependent manner, while 20 microM of myristoylated PKC [19-27] pseudosubstrate, given as a control, had no effect. Stimulation of fibronectin mRNA level by IL-1beta (1 ng/mL) was completely prevented by 20 microM of my ristoylated PKC zeta/iotapseudosubstrate. IL-1beta (1 ng/ mL) increased phosphorylated PKC zeta/iota, an active form of the enzyme. CONCLUSION: IL-1beta-induced fibronectin production in HPMCs occurs by way of activation of atypical PKCs (PKC zeta/iota).
